Table IV.
Treatment and outcome for extranodal NK/T-cell lymphoma with hematopoietic cell transplantation.
| Author (year) | N | Transplant regimen (n) | Patient characteristics at transplant (n) | Outcomes
|
|
|---|---|---|---|---|---|
| % CR | % OS (y) | ||||
| Takenaka et al. (2001) [68] | 3 | Auto (2), Allo (1) | SD or PD (3) | 67 | 67 (5y) |
| Au et al. (2003) [69] | 18 | Auto (18) | CR1 (7), CR2 (5) | 58 | NR |
| Murashige (2005) [70] | 28 | Allo (28) | 22 extranodal, CR (8), SD or PD (20) | NR | 40 (2y) |
| Kim et al. (2006) [71] | 16 | Auto (16) | CR1 or CR2 (9), SD or PD (7) | 75 | 71 (2y) |
| Suzuki et al. (2006) [72] | 40 | Auto (25), Allo (15) | 22 extranodal, SD or PD (18) | NR | 39 (4y) |
| CR (22) | NR | 68 (4y) | |||
Y, year; Auto, autologous; Allo, allogeneic; CR, complete remission; SD, stable disease; PD, progression of disease; OS, overall survival; NR, not reported.